MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 10, 2004; DOI: 10.1124/mol.104.002303


0026-895X/04/6606-1421-1430$20.00
Mol Pharmacol 66:1421-1430, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002303v1
66/6/1421    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gendron, L.
Right arrow Articles by Beaudet, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gendron, L.
Right arrow Articles by Beaudet, A.

Low-Affinity Neurotensin Receptor (NTS2) Signaling: Internalization-Dependent Activation of Extracellular Signal-Regulated Kinases 1/2

Louis Gendron, Amélie Perron, Marcel Daniel Payet, Nicole Gallo-Payet, Philippe Sarret, and Alain Beaudet

Department of Neurology and Neurosurgery (L.G., A.P., P.S., A.B.), Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada; and Department of Physiology and Biophysics (M.D.P.), Faculty of Medicine, and Service of Endocrinology (N.G.P.), University of Sherbrooke, Sherbrooke, Quebec, Canada

The role and signaling properties of the low-affinity neurotensin receptor (NTS2) are still controversial. In particular, it is unclear whether neurotensin acts as an agonist, inverse agonist, or antagonist at this site. In view of the growing evidence for a role of NTS2 in antinociception, the elucidation of the pharmacological and coupling properties of this receptor is particularly critical. In the present study, we demonstrate that in Chinese hamster ovary (CHO) cells expressing the rat NTS2 receptor, neurotensin (NT), levocabastine, neuromedin N, and the high-affinity NT receptor antagonist SR48692 [2-{[1-(-7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carbonyl]amino}adamantane-2-carboxylic acid] all bind to and activate the NTS2 receptor. This activation is followed by ligand-induced internalization of receptor-ligand complexes, as evidenced by confocal microscopy using a fluorescent NT analog. All compounds tested produced a rapid and sustained activation of extracellular signal-regulated kinases 1/2 (ERK1/2) but were without specific effect on Ca2+ mobilization. The agonist-induced activation of ERK1/2 was completely abolished by preincubation of the cells with the endocytosis inhibitors phenylarsine oxide and monodansylcadaverine as well as overexpression of a dominant-negative mutant of dynamin 1 (DynK44A), indicating that receptor internalization was required for ERK1/2 activation. NTS2-induced activation of ERK1/2 was not species-specific, because the same agonistic effects of NT and analogs were observed in CHO cells transfected with the human NTS2 receptor. In conclusion, this study demonstrates that NTS2 is a bona fide NT receptor and that activation of this receptor by NT or NT analogs results in an internalization-dependent activation of the ERK1/2 signaling cascade.


Received May 4, 2004; accepted September 9, 2004

Address correspondence to: Dr. Alain Beaudet, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Room 896, 3801 University St., Montreal, Quebec, Canada, H3A 2B4. E-mail: alain.beaudet{at}mcgill.ca




This article has been cited by other articles:


Home page
J BiochemHome page
N. Sevillano, M. D. Giron, M. Salido, A. M. Vargas, J. Vilches, and R. Salto
Internalization of the Receptor for Advanced Glycation End Products (RAGE) is Required to Mediate Intracellular Responses
J. Biochem., January 1, 2009; 145(1): 21 - 30.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. Schulz, C. Rocken, M. P A Ebert, and S. Schulz
Immunocytochemical identification of low-affinity NTS2 neurotensin receptors in parietal cells of human gastric mucosa.
J. Endocrinol., October 1, 2006; 191(1): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Perron, P. Sarret, L. Gendron, T. Stroh, and A. Beaudet
Identification and Functional Characterization of a 5-Transmembrane Domain Variant Isoform of the NTS2 Neurotensin Receptor in Rat Central Nervous System
J. Biol. Chem., March 18, 2005; 280(11): 10219 - 10227.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics